Aspo Plc
Aspo Plc: Share repurchase 9.12.2025
Aspo Plc: Share repurchase 9.12.2025
| Aspo Plc | ANNOUNCEMENT | 9.12.2025 | |
| Aspo Plc: Share repurchase 9.12.2025 | |||
| In the Helsinki Stock Exchange | |||
| Trade date | 9.12.2025 | ||
| Bourse trade | Buy | ||
| Share | ASPO | ||
| Amount | 3 000 | Shares | |
| Average price/ share | 6,7186 | EUR | |
| Total cost | 20 155,80 | EUR | |
| Aspo Plc now holds a total of 78 555 shares | |||
| including the shares repurchased on 9.12.2025 | |||
| The share buybacks are executed in compliance with Regulation | |||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | |||
| and the Commission Delegated Regulation (EU) 2016/1052. | |||
| On behalf of Aspo Plc | |||
| Nordea Bank Oyj | |||
| Sami Huttunen | Ilari Isomäki | ||
| For more information, please contact: | |||
| Erkka Repo, CFO, Aspo Plc, tel. +358 40 5827 971, erkka.repo@aspo.com | |||
| www.aspo.com | |||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Nilfisk Holding A/S11.12.2025 07:46:07 CET | Press release
Revised full-year 2025 outlook
Aukera Therapeutics11.12.2025 07:30:00 CET | Press release
Aukera Therapeutics Comes Out of Stealth
Sampo plc11.12.2025 07:30:00 CET | Press release
Sampo plc’s share buybacks 10 December 2025
Basilea Pharmaceutica AG, Allschwil11.12.2025 07:15:00 CET | Press release
Basilea and Phare Bio enter partnership combining anti-infectives industry expertise with unique AI capabilities for the development of a novel antibiotic
Zealand Pharma11.12.2025 07:05:00 CET | Press release
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom